Closure of Ameridose, sister company of pharmacy in meningitis outbreak, extended 2 weeks

By Kay Lazar, Globe Staff

A Westborough pharmacy and drug manufacturer with the same owners as the Framingham specialty phamacy at the center of the national fungal meningitis outbreak will remain closed until at least Nov. 19.

The temporary closure of Ameridose LLC, by mutual agreement with state regulators Friday, was extended two weeks to give investigators more time to complete an inspection of the facility, after the company recalled its products this week.

The Massachusetts Hospital Association released a statement saying the continued shutdown of Ameridose, which supplies more than 3,000 hospitals nationwide, “heightens Massachusetts hospitals’ concerns about the possibility of prolonged and serious shortages of important medications.”

Ameridose had been scheduled to reopen Monday, but this past Wednesday it agreed to recall all its products after federal investigators identified shortcomings in its safety testing. The company acted on the recommendation of the US Food and Drug Administration but said it issued the recall voluntarily and had not received any reports of illness.

A letter dated Friday and signed by the president of the Board of Registration in Pharmacy and a lawyer for Ameridose states that the “board finds it necessary to extend the Agreement to conduct a comprehensive investigation of the facility operations.”

Hospital leaders said the extended closure has forced hospital staff to work around the clock making drugs in their own pharmacies because many of the medications in short supply are routinely needed in operating rooms.

The hospital association said that the hospital community continues to work with state health officials “to address the escalating drug shortages, and Massachusetts hospitals are looking to the appropriate state and federal agencies to help identify and secure safe alternative sources for critically needed medications.”